Clinical Research Directory

Inclusion Criteria * Patients aged 18 years or older diagnosed with pulmonary mucormycosis (PM). * Individuals with Probable or proved PM, as indicated by clinical and radiological findings. Exclusion Criteria: * Patients with a history of pulmonary mucormycosis (PM) who have previously been treated with amphotericin B for a duration exceeding 5 days. * Patients who have documented allergies to azoles or amphotericin B regimens * Patients with serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, or bilirubin levels exceeding five times the upper limit of normal (ULN). * Patients with irreversible heart or liver failure, or those experiencing massive, fatal hemoptysis. * Patients who have experienced a myocardial infarction or cerebral infarction. * Patients currently receiving extracorporeal membrane oxygenation (ECMO) treatment. * Pregnant or breastfeeding individuals. 8.Patients with individual reasons that may prevent them from completing the treatment protocol.